13.31
0.60%
-0.08
Handel nachbörslich:
13.31
Takeda Pharmaceutical Co ADR Aktie (TAK) Neueste Nachrichten
Takeda and AC Immune ink $2.1 billion Alzheimer's therapy deal - Investing.com India
Investing.com India
Takeda stock down 1% as operating profit declines - Investing.com India
Investing.com India
Proton Pump Inhibitors Market In-depth Analysis, Rising Business Opportunities And Estimated Forecast Till 2031 ... - openPR
openPR
Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Zacks Investment Research
Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Zacks Investment Research
All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
Zacks Investment Research
TAK or CTLT: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
Zacks Investment Research
Best Value Stocks to Buy for April 25th
Zacks Investment Research
Best Income Stocks to Buy for April 25th
Zacks Investment Research
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Zacks Investment Research
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
TAK or STVN: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Zacks Investment Research
Weekly Upgrades and Downgrades - InvestorPlace
InvestorPlace
Weekly Upgrades and Downgrades - InvestorPlace
InvestorPlace
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Zacks Investment Research
One Ultra-Cheap High-Yield Dividend Stock to Buy
The Motley Fool
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
Benzinga
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?
Zacks Investment Research
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Zacks Investment Research
MORF Stock Collapses 55% Over Two Days As Takeda Rivalry Slams Ulcerative Colitis Drug - Investor's Business Daily
Investor's Business Daily
CDSCO raises alert on fake Adcetris injection manufactured by Takeda Pharma - Medical Dialogues
Medical Dialogues
CDSCO raises alert on fake Lymphoma drug Adcetris Injection manufactured by Takeda Pharma - Medical Dialogues
Medical Dialogues
Big Pharma keeps on coming to Boston: 'That's where the action is' - Boston Business Journal - The Business Journals
The Business Journals
CDMO: Is Your Portfolio Healthy? Don't Touch This Stock With a Ten-Foot Pole! - StockNews.com
StockNews.com
IgA Nephropathy Clinical Trials Pipeline Analysis: 30+ Companies are Working to Improve the Treatment Space ... - GlobeNewswire
GlobeNewswire
6 Undervalued Stocks With Low Beta - Morningstar
Morningstar
Takeda Stock: Undervalued And Potential Upside (NYSE:TAK) - Seeking Alpha
Seeking Alpha
Nichi-Iko Pharma seeks debt restructuring aided by white knight - Nikkei Asia
Nikkei Asia
Revealed: the pharma companies best equipped with AI - Clinical Trials Arena
Clinical Trials Arena
Top 20 Pharmaceutical Companies by Revenue 2021 - FiercePharma
FiercePharma
Current Cathie Wood Portfolio 2020: Ark Invest Holdings - New Trader U
New Trader U
The top 15 pharma companies by 2026 sales - FiercePharma
FiercePharma
Here are the drugs the FDA says are OK to take in place of recalled Zantac - Fox Business
Fox Business
How Takeda CEO Sells Japan's Biggest Deal to Doubters - Bloomberg
Bloomberg
Nektar Therapeutics Stock Is Risky But Offers Big Reward - InvestorPlace
InvestorPlace
Kapitalisierung:
|
Volumen (24h):